Stay updated on AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.

Latest updates to the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page
- Check5 days agoChange DetectedA 403 Forbidden error is now displayed on the study record page, making the detailed study content inaccessible. This change blocks access to the study's information and reflects an access-restriction rather than new data updates.SummaryDifference17%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a minor maintenance update to the ClinicalTrials.gov entry. This update does not reflect changes in the study data.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page content has been replaced with a generic error page (500) and the detailed Migalastat Fabry disease study information has been removed.SummaryDifference16%

- Check62 days agoChange DetectedThe page's revision indicator was updated from v3.6.3 to v3.6.4, reflecting a minor update to the page's version metadata.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision label now reads v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's release/version information.SummaryDifference0.1%

- Check90 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's content or backend without changing study details.SummaryDifference0.1%

Stay in the know with updates to AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.